Literature DB >> 4239247

[Demonstration of a new reactive metabolite in metabolism of phenazone (antipyrine)].

G Wittemann, R Schüppel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4239247

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol


× No keyword cloud information.
  4 in total

1.  Disposition of antipyrine in patients with extensive metastatic liver disease.

Authors:  G M Robertz-Vaupel; K D Lindecken; T Edeki; C Funke; S Belwon; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Antipyrine metabolite formation and excretion in patients with chronic renal failure.

Authors:  M W Teunissen; D Kampf; I Roots; N P Vermeulen; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man.

Authors:  H Bässmann; J Böttcher; R Schüppel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

4.  Irreversible binding of 3-14C-antipyrine to hepatic protein in vivo and in metabolizing liver microsomes.

Authors:  S Tabarelli-Poplawski; H Uehleke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.